Revolutionary US Medical Technology Takes Center Stage at Vietnam’s Largest Healthcare Exhibition

Advanced Cold Plasma System from General Vibronics Captures Attention of Medical Professionals During Three-Day Industry Showcase

A groundbreaking medical device utilizing cold atmospheric plasma technology emerged as a key highlight during Vietnam’s premier healthcare industry event, held from July 31 to August 2, 2025, at the Saigon Exhibition and Convention Center (SECC). The revolutionary Mirari Cold Plasma System, developed by US-based General Vibronics, drew significant attention from healthcare professionals and industry experts attending the international medical exhibition.

FDA-Cleared Innovation Debuts in Southeast Asian Market

The portable medical device, which received FDA clearance in November 2024 (Certificate No. K242553), represents a significant advancement in non-invasive therapeutic technology. Unlike traditional treatment methods, the system generates cold atmospheric plasma at room temperature while delivering therapeutic benefits through controlled biochemical reactions without causing thermal damage to healthy tissues.

General Vibronics’ proprietary technology operates at 80 kHz frequency with adjustable power settings ranging from 2-4 watts, allowing healthcare practitioners to customize treatments based on individual patient requirements. The handheld device creates reactive oxygen species (ROS) and nitric oxide-based plasma to deliver antimicrobial, anti-inflammatory, and regenerative effects.

Diverse Medical Applications Showcase Treatment Versatility

During the exhibition, visitors witnessed demonstrations of the technology’s multi-disciplinary applications across various medical specialties. The system’s therapeutic capabilities span:

• Wound healing and tissue regeneration for diabetic ulcers, surgical wounds, and chronic conditions
• Dermatological treatments including acne management and skin restoration procedures
• Pain management for musculoskeletal conditions and post-injury rehabilitation
• Cosmetic applications for scar treatment and post-surgical recovery
• Immune system support and general wellness enhancement

The device’s 20-hour treatment array capacity and 15-minute session duration make it particularly suitable for outpatient clinics and various healthcare settings.

International Recognition Drives Market Expansion

The Mirari Cold Plasma System has garnered multiple international accolades, including the Best Innovation Award in North America at the JWC London conference in March 2017, and the Best Poster Award from the World Union of Wound Healing Societies in Florence, Italy. The technology has also received regulatory approval from Thailand’s Food and Drug Administration and Vietnam’s Ministry of Health.

Mirari Doctor, the exclusive distributor for the Vietnamese market, emphasized the system’s role in advancing healthcare standards through international technology transfer. The collaboration between Vietnamese and American companies demonstrates the growing integration of cutting-edge medical technologies into Southeast Asian healthcare systems.

Technology Exhibition Draws Global Participation

The Vietnam Medipharm Expo 2025 attracted 450 exhibitors from 23 countries and territories, welcoming approximately 12,000 visitors including physicians, distributors, manufacturers, and importers. The three-day event featured companies from Austria, the European Union, United States, India, Japan, Republic of Korea, Malaysia, Singapore, China, and Turkey showcasing products across 500 exhibition booths.

Specialized seminars during the event covered current pharmaceutical regulations, AI integration in healthcare, green technology innovation, and sustainable medical device production, providing comprehensive insights into industry trends and regulatory developments.

The prominent display of advanced cold plasma technology alongside artificial intelligence solutions, robotic diagnostic equipment, traditional aesthetic devices, and pharmaceutical production lines highlighted the rapid evolution of medical technology adoption in Vietnam’s healthcare sector. This technological integration reflects the country’s commitment to modernizing healthcare delivery and improving patient outcomes through international collaboration and innovation transfer.

Images from the Mirari booth at the 2025 Ho Chi Minh City International Medical and Pharmaceutical Exhibition: